SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-19-029652
Filing Date
2019-08-07
Accepted
2019-08-07 07:21:52
Documents
113
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q hznp-10q_20190630.htm   iXBRL 10-Q 5346834
2 EX-10.5 ex105.htm EX-10.5 13827
3 EX-10.6 ex106.htm EX-10.6 13724
4 EX-31.1 hznp-ex311_861.htm EX-31.1 16075
5 EX-31.2 hznp-ex312_860.htm EX-31.2 15837
6 EX-32.1 hznp-ex321_859.htm EX-32.1 8960
7 EX-32.2 hznp-ex322_858.htm EX-32.2 8923
  Complete submission text file 0001564590-19-029652.txt   18667616

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA hznp-20190630.xsd EX-101.SCH 108295
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE hznp-20190630_cal.xml EX-101.CAL 84484
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE hznp-20190630_def.xml EX-101.DEF 473738
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE hznp-20190630_lab.xml EX-101.LAB 714910
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE hznp-20190630_pre.xml EX-101.PRE 662452
13 EXTRACTED XBRL INSTANCE DOCUMENT hznp-10q_20190630_htm.xml XML 4133535
Mailing Address CONNAUGHT HOUSE, 1ST FLOOR 1 BURLINGTON ROAD DUBLIN L2 4
Business Address CONNAUGHT HOUSE, 1ST FLOOR 1 BURLINGTON ROAD DUBLIN L2 4 011-353-1-772-2100
Horizon Therapeutics Public Ltd Co (Filer) CIK: 0001492426 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35238 | Film No.: 191003821
SIC: 2834 Pharmaceutical Preparations